- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06064318
Prevalence and Incidence of Multiple Revisions Following Knee Arthroplasty in Denmark 1998-2021: A Nationwide Population-based Study (EMKAR ONE)
April 9, 2024 updated by: Julius Tetens Hald, Rigshospitalet, Denmark
The purpose of this study is to investigate the incidence and prevalence rates of multiply revised knee arthroplasty patients in Denmark from 1998-2021.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
161384
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Rigshospitalet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
All Danish residents between the ages of 18-99 who received a primary knee arthroplasty in Denmark between 1998-2021.
Description
Inclusion Criteria:
- Danish Resident
- between 18-99 years of age
- must have had primary knee arthroplasty procedure performed in Denmark between 1998-2021
Exclusion Criteria:
- Missing key variables (patient ID, date of surgery, procedure-code, laterality of procedure)
- Duplicates
- Non-relevant procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Primary cohort
All patients with a primary knee arthroplasty performed in Denmark between Jan 1st 1998 and 31st December 2021.
|
|
Revision cohort
All patients with a revision knee arthroplasty performed in Denmark between Jan 1st 1998 and 31st December 2021
|
Any type of knee revision, excluding knee arthrodesis and femur amputation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of major n-grade revisions
Time Frame: 23 years
|
standardized prevalence of major n-grade revisions
|
23 years
|
Incidence of major n-grade revisions
Time Frame: 23 years
|
standardized incidence of major n-grade revisions
|
23 years
|
Prevalence of all n-grade revisions
Time Frame: 23 years
|
standardized prevalence of all n-grade revisions
|
23 years
|
Incidence of all n-grade revisions
Time Frame: 23 years
|
standardized incidence of all n-grade revisions
|
23 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of major and all n-grade revisions stratified by sex and age
Time Frame: 23 years
|
Calculation of incidence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99)
|
23 years
|
Prevalence of major and all n-grade revisions stratified by sex and age
Time Frame: 23 years
|
Calculation of prevalence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99)
|
23 years
|
Prevalence of major and all n-grade revisions for patients with their total sum of revisions
Time Frame: 23 Years
|
Calculation of standardized prevalence for patients receiving major or all type of n-grade revision, where the ordering of revisions are not knee specific but patient-specific
|
23 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
September 2, 2023
Study Completion (Actual)
April 1, 2024
Study Registration Dates
First Submitted
September 26, 2023
First Submitted That Met QC Criteria
September 26, 2023
First Posted (Actual)
October 3, 2023
Study Record Updates
Last Update Posted (Actual)
April 10, 2024
Last Update Submitted That Met QC Criteria
April 9, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 08062023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Sharing IPD is not available as the data is protected by GDPR regulations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Replacement
-
Central DuPage HospitalTerminatedTotal Knee Replacement | Replacement, Total Knee | Arthroplasty, Knee ReplacementUnited States
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
Istituto Ortopedico GaleazziUnknown
-
DC2 HealthcareNational Research Independent Operations Management; Clinical Care Continuum...Unknown
-
Fondazione Don Carlo Gnocchi OnlusCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipItaly
-
Molnlycke Health Care ABCompletedArthroplasties, Hip Replacement | Arthroplasties, Knee ReplacementUnited States
-
Bornholms RegionskommuneCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipDenmark
-
Grupo de Estudos e Pesquisas Sobre Atividade Física...CompletedKnee Replacement | Hip Replacement | Postural Balance
-
Campus Bio-Medico UniversityRecruitingArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipItaly
-
SCRI Development Innovations, LLCWithdrawnArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipUnited States
Clinical Trials on Revision
-
Orthopaedic Innovation CentreActive, not recruiting
-
Unity Health TorontoUnknownArthroplasty Complications | Total Hip Replacement
-
Universidad Complutense de MadridNot yet recruiting
-
Charite University, Berlin, GermanyAesculap AGUnknownRevision Total Knee Arthroplasty Because of | Loosening | Instability | Impingement | or Other Reasons Accepted as Indications for TKA Exchange. | The Focus is to Determine the Precision of Joint Line Restoration in Navigated vs. Conventional Revision Total Knee ArthroplastyGermany
-
DePuy OrthopaedicsActive, not recruitingRevision Total Knee ArthroplastyUnited States, Netherlands, New Zealand, France, United Kingdom, Canada, Australia, Austria, Belgium, Germany, Ireland, Italy, Switzerland
-
MicroPort Orthopedics Inc.Active, not recruitingJoint DiseaseUnited Kingdom
-
Aesculap AGB.Braun Surgical SAActive, not recruitingKnee Osteoarthritis | Prosthesis-Related Infections | Prosthesis Failure | Bone; Deformity, CongenitalSpain
-
Odense University HospitalRecruitingPeriprosthetic Knee InfectionDenmark
-
General Committee of Teaching Hospitals and Institutes...Not yet recruitingWeight Loss | Bariatric Surgery Candidate | Nutrient Deficiency | Comorbidities and Coexisting ConditionsEgypt
-
Institut Paoli-CalmettesCompleted